Margaret Gatti-Mays: To avoid adjuvant chemotherapy in small HER2+ breast tumors

Margaret Gatti-Mays, Co-Director of the Division of Medical Oncology at the Ohio State University, shared on X:

“Growing data that may be able to avoid adjuvant chemotherapy in small (5mm or less) HER2+ breast tumors. Great collaboration with CancerLinQ, The James, Ohio State Medical Oncology lead by Dr Kai Johnson, Dr Wesolowski.”

Read further.
Source: Margaret Gatti-Mays/X